Los Angeles Capital Management
NUVB icon

Los Angeles Capital Management’s Nuvation Bio NUVB Stock Holding History

Los Angeles Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Buy
58,429
+56,272
+2,609% +$275K ﹤0.01% 1025
2026
Q1 		$9.25K Sell
2,157
-50,116
-96% -$279K ﹤0.01% 1972
2025
Q4 		$269K Sell
52,273
-53,747
-51% -$333K ﹤0.01% 1132
2025
Q3 		$392K Hold
106,020
– – ﹤0.01% 1022
2025
Q2 		$207K Buy
+106,020
New +$221K ﹤0.01% 1187

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Los Angeles Capital Management's NUVB Position: Q2 2026 in Review

Los Angeles Capital Management increased its Nuvation Bio (NUVB) stake by 2,609% in Q2 2026, buying an estimated $275K and bringing the position to 58,429 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Los Angeles Capital Management first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $392K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Los Angeles Capital Management held 58,429 shares of Nuvation Bio worth $332K as of Q2 2026.
  • Los Angeles Capital Management bought 56,272 Nuvation Bio shares in Q2 2026, an estimated $275K.
  • Nuvation Bio made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1025 holding.
  • Los Angeles Capital Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Los Angeles Capital Management's Nuvation Bio position peaked at $392K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.